Answers are grounded in this paper and cite their sources.
SARS-COV2 infection has been linked to cardiovascular complications. Published data suggest that cardiac injury may be a common disease feature and contribute to morbidity and mortality in severe COVID-19. Since early in the pandemic, little data has emerged describing what cardiovascular complications arise from myocardial injury in severe COVID-19 and whether these complications contribute to mortality. We set out to describe the incidence and nature of cardiovascular complications in patients with severe COVID-19 infection and biochemical or imaging evidence of myocardial injury. We analyzed consecutive patients admitted for severe COVID-19 and presenting with biochemical or echocardiographic evidence of myocardial injury across 16 centers within the CARDIO-COVID investigator-initiated consortium. A light-GBM machine learning model was used to identify variables associated with mortality. Our study included 1,328 patients. ICU mortality was 29.4%. Factors most associated with mortality were age, SOFA Cardiovascular score, elevated troponin, intubation, high vasoactive-inotropic score (VIS), high PEEP, and high FiO2. Individual cardiovascular (myocardial infarction, stroke, pulmonary embolism, myocarditis, VT/VF, new onset heart failure) complications were rare (all < 5%) but common in sum (17.6%), and did not present significant association with mortality. Patients with high VIS and SOFA Cardiovascular scores had a significantly higher incidence of secondary bacterial pneumonias suggesting septic shock played a role in their physiology. Investigator-adjudicated cause of death data identified respiratory failure and septic shock as primary causes of mortality. Though cardiovascular complications of severe COVID-19 are common, they do not seem to contribute significantly to mortality. Elevated cardiac enzymes and myocardial dysfunction carry prognostic value likely reflecting myocardial strain in the setting of multisystem organ dysfunction rather than direct myocardial injury by SARS-CoV2.
No takes yet. Share an insight, caveat, or question.
O’Brien et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: